Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS 

Investorideas podcasts on iTunes, Google Play Music and    Bitcoin and Blockchain Stocks    Play by Play – the latest sports headlines and sports stock news


Investor Research for Marijuana Stocks

Marijuana / Hemp Stocks

News and stock research at and

Like Marijuana / Hemp Stocks? Check out our Marijuana / Hemp Stocks Directory for investors

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Also check out our blog Global Cannabis Investing

Featured marijuana stocks

CannaSOS is a comprehensive social network and advertising platform geared towards worldwide cannabis industry. CannaSOS is divided into multiple sections: Strain Database, Pulse, Advice, Business, Store, News, Social, all developed primarily to generate leads for businesses.

Since opening the doors to the public in January of 2014, CannaSOS acquired over 315,000+ registered members, 970+ active business pages, 4,900+ marijuana strain database, 200+ social groups, 8,500+ user strain reviews, over 3,900,000 strain page views, 2380 posted advice Q/A, 3700+ posted articles, and much more.

Buy PerkCoins

Featured marijuana stocks featured marijuana company - SinglePoint, Inc. (OTCQB:SING)

SinglePoint, Inc.


SinglePoint, Inc (OTCQB:SING) is a technology company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The company portfolio includes mobile payments, daily fantasy sports, ancillary cannabis services and blockchain solutions. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base.

Get News Alerts on SinglePoint, Inc. at #CSE's 'Cannabis in the Capital Markets' in Kelowna

Interview with Timothy Taggart, CEO of American Growth Fund Series Two (AMREX), currently the only Cannabis Mutual Fund in the US

Marijuana News

Investor Ideas 'Potcast'; #Cannabis News and Stocks on the Move ; CSE: $LILY.C, OTCQB: $MPHMF, OTC: $NGTIF, OTCQB: $CLSH
Pt. Roberts, WA; Delta, BC - May 21, 2018 ( Newswire), a global news source covering leading sectors including marijuana and hemp stocks and its 'potcast' site, release today's edition of its new series, potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts.

Investor Ideas 'Potcast'; Interview with #MS survivor Montel Williams, one of the highest-profile medical #cannabis patients in the U.S. @Montel_Williams
Pt. Roberts, WA; Delta, BC - May 18, 2018 ( Newswire), a global news source covering leading sectors including marijuana and hemp stocks and its 'potcast' site, release today's edition of its new series, potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts.

Viridian to Moderate Institutional Investor Panel at The #MedMen Institutional Capital & #Cannabis Conference in Los Angeles
New York, NY - May 18, 2018 ( Newswire) Viridian Capital Advisors is pleased to announce that Scott Greiper, its President and founder, will moderate the Institutional Investor panel at the 2nd Annual MedMen/IMN Institutional Capital & Cannabis Conference taking place in Los Angeles, California this coming Monday, May 21 and Tuesday, May 22.

House Appropriations Committee Votes to Continue Blocking Justice Department From Interfering in State #Medical #Marijuana Laws
WASHINGTON - May 17, 2018 ( Newswire) The House Appropriations Committee voted Thursday to continue blocking the Justice Department from interfering in state medical marijuana laws.

Investor Ideas 'Potcast'; #Cannabis News and Stocks on the Move; (CSE: $GLH.C), (CSE: $AFI.C), (CSE: $ATT.C), (TSXV: $CBW.V)
Pt. Roberts, WA; Delta, BC - May 17, 2018 ( Newswire), a global news source covering leading sectors including marijuana and hemp stocks and its 'potcast' site, release today's edition of its new series, potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts.

Tetra Natural Health (TSX-V: $TBP.V) (OTCQB: $TBPMF) Signs a Supply Agreement with Namaste Technologies (TSX-V: $N.V) for the Marketing and Distribution of Rx Princeps, its Premium Medicinal #Cannabis Product
OTTAWA - May 17, 2018 ( Newswire) Tetra Natural Health a division of Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V:TBP) (OTCQB:TBPMF) and - Namaste Technologies Inc. ("Namaste" or the "Company") (TSX-V:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that the Company has signed a Supply Agreement (the "Supply Agreement") for the sale and distribution of Rx Princeps

Pivot (CSE: $PVOT.C, OTCQB: $PVOTF) Signs Manufacturing and Supply Agreement With California-Based Stoney LLC
VANCOUVER - May 17, 2018 ( Newswire) Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that its wholly-owned California subsidiary, Pivot Naturals, LLC has signed a Definitive Manufacturing and Supply Agreement ("the Agreement") with Stoney LLC ("Stoney"), a leading brand of cannabis products in the state of California.

Relevium (TSX.V:RLV) (OTCQB:RLLVF) Engages PipeDreemz as Lead ACMPR Consultant for #Biocannabix
MONTREAL - May 17, 2018 ( Newswire) Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the "Company" or "Relevium"), is pleased to announce it has engaged PipeDreemz as lead consultant (the "Consultant") for the Biocannabix Health Corp ("BHC") ACMPR applications to Health Canada to obtain the necessary licenses.

Montel Williams' Lenitiv Scientific And Cura Cannabis Solutions Announce Deal To Produce Williams' Lenitiv line
PORTLAND, Ore - May 17, 2018 ( Newswire) Cura, a leading provider of cannabis oil, has reached an agreement to produce a hemp-derived and a cannabis-derived line for Lenitiv.

Investor Ideas 'Potcast'; #Cannabis News and Stocks on the Move; (CSE: $BE.C), (TSXV: $SCYB.V), (OTCQX: $GRWG), (TSXV: $GENE.V), (OTC: $ IVITF)
Pt. Roberts, WA; Delta, BC - May 16, 2018 ( Newswire), a global news source covering leading sectors including marijuana and hemp stocks and its 'potcast' site, release today's edition of its new series, potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts.

Subscribe to Marijuana News RSS

Submit Articles Search More Articles potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts

Investor Ideas 'Potcast'; #Cannabis News and Stocks on the Move; CSE: LILY, OTCQB: MPHMF, OTC: NGTIF, OTCQB: CLSH

Investor Ideas 'Potcast'; Interview with #MS survivor Montel Williams, one of the highest-profile medical #cannabis patients in the U.S. potcast - cannabis news and stocks to watch CSE: CSE: GLH, CSE:AFI, CSE:ATT, TSXV:CBW potcast - cannabis news and stocks to watch CSE: BE, TSXV: SCYB, OTCQX: GRWG, TSXV: GENE, OTC: IVITF potcast - cannabis news and stocks to watch TSX: WEED, NADAQ: CRON, CSE: MYM, TSX:TRST

#Cannabis Stocks on the Move - Aurora Cannabis (TSX: $ACB.TO) and MedReleaf (TSX: $LEAF.TO) Acquisition

Interview with Andrew Duffy CEO of Best in Grow

Mike Gorenstein of NASDAQ:CRON - Evolution of the Cannabis industry and why Israel is still number one

Sean McCabe from Electrum Partners: Everything you need to know about the Cannabis sector in under ten minutes

Troy Dayton, CEO of Arcview Group – why you should be watching Germany; Cannabis and AgTech - a Huge opportunity

Ted Ohashi MBA, CFA of 'Let's Toke Business' Talking about Canadian Cannabis Stocks

Investor Ideas Talks to Canopy Growth (TSX: $WEED.TO) and Aurora Cannabis (TSX: $ACB.TO) at Lift Cannabis Expo 2018

Wil Ralston of SinglePoint (OTC: $SING) Talking about Developments in Cryptocurrency talks to Wil Ralston of SinglePoint ($SING) about Acquisition Strategy speaks with Greg Lambrecht, CEO of SinglePoint (OTC:SING) on the company's move into the cannabis space and recent acquisitions and growth

Investor Ideas talks to CEO about Nature's Dream and its marijuana strain finder app Cannacopia

Interview with Steve Hawkins- World's First Marijuana ETF - Horizons Medical Marijuana Life Sciences (TSX: HMMJ)

Leslie Bocskor of Electrum Partners talks about the once in a lifetime opportunity in the cannabis industry talks to CEO of Cannabis Mutual Fund in the US

Subscribe to Cannabis Podcasts RSS

Sponsored Content

Cannabis Law News | Cannabis Law Report

New Frontier Cannabis News

Expert Corner - Lets Toke Business

Ted Ohashi MBA, CFA

Ted Ohashi MBA, CFA

Published Weekly Since 2014. Latest Issue...

To learn about subscribing email:

Marijuana / Hemp Stock Directory Preview

22nd Century Group Inc. (NYSE MKT:XXII) is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants through genetic engineering and plant breeding. The Company's primary mission is to reduce the harm caused by smoking. 22nd Century currently owns or exclusively controls more than 200 issued patents and more than 50 pending patent applications around the world. The Company's strong IP position led to a licensing agreement with British American Tobacco ("BAT"), the world's second largest tobacco company.

3DX Industries Inc. (OTC: DDDX) is focused on the additive metal manufacturing segment within the manufacturing industry. 3DX has the capability of manufacturing a wide variety of products using its 3D metal printing system, 3D composite printing as well as more traditional methods of precision manufacturing. 3DX offers additive and subtractive manufacturing options as well as product design, engineering and assembly services to its customers. Cannabis: Has completed the development and design of a new and innovative product used for recovering excess heat from high energy grow lights. The part was designed specifically for the legalized cannabis markets including medical marijuana using the company's 3D Metal printing -- Binder Additive manufacturing process and is expected to be installed in select licensed facilities for real world testing in the coming months.

ABATTIS BIOCEUTICALS (OTC:ATTBF; CSE:ATT) is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America. The Company is positioned to capitalize on the fast growing trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions, by supplying and partnering with companies to employ its mass cultivation systems, extraction equipment/technology, and strategic marketing support to licensed growers. The Company also has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions.

ABcann Global Corporation (TSX:ABCN.V) was one of the first companies to obtain a production license under the Marijuana for Medical Purposes Regulations, which it received on March 21, 2014. It obtained a sales license on December 31, 2015. ABcann's flagship facility, in Napanee, Ontario, contains proprietary plant-growing technology, including environmentally-controlled chambers capable of monitoring and regulating all variables in the growing process. This approach and the systems in place allow ABcann to produce organically grown and pesticide-free, high-yielding plants, which, in turn, can generate high-quality products that are consistent from batch to batch. ABcann is able to control environmental and nutrient demands, tailor-made for a particular strain of cannabis, without the variation that is typical when producing large quantities in less-controlled, larger rooms and greenhouse-type structures. ABcann's modular approach to systems technology eliminates scale-up risk and allows ABcann to locate anywhere in the world and maintain consistency and quality of product. ABcann is expanding capacity in its current facility to approximately 30,000 sq ft and concurrently undertaking expansion into a new 150,000 sq ft facility in Napanee. ABcann is pursuing opportunities in Germany, Australia and other jurisdictions as well as exploring the development of multiple delivery vehicles.

Acology Inc (OTC:ACOL) markets and sells the TSOS Container™ (The Science of Storage).This container is the first-ever FDA approved polypropylene air-tight, water-tight, smell-proof delivery and storage container with a built-in grinder. It is manufactured from medical-grade No. 5 polypropylene resin, which is non-porous and non-leaching. These containers are portable and affordable. he Medtainer™ allows patients to store, grind and pour a variety of medications, including pills and all sizes and solidity, herbal medications and teas and even coffee and spices! The Medtainer™ can be ordered in with a certified child-resistant cap. Each Medtainer™ is water-proof and smell proof. Caregivers who are responsible for ensuring their patients medication regimens are universally pleased with the how easy and effective the Medtainer™ grind medications. It is an excellent solution for patients with dysphasia due to cognitive disorders or brain injuries, are in hospice or palliative situations and for anyone who would rather not swallow whole pills. The MedTainer™ was originally developed for geriatric and pediatric patients who had difficulty swallowing pills or needed an effective alternative to costly name-brand medications. The MedTainer™ has been sold and is being successfully used throughout the United States, Canada, Mexico and South America and Europe. Our association with the Medical Marijuana community was an unexpected windfall that has given Acology, Inc. the necessary funding to expand into the growing hospice and palliative care markets, and to help countless patients who are living at home or in small home-like settings and need help swallowing pills.

Advantis Corp (OTC:ADVT) develops products and works with developing companies to provide innovative healthcare products, holistic pain management solutions, and enhance the footprint in the evolving legal cannabis business. Advantis acquires ownership in developing companies that work within the nutraceutical and the alternative health care industries; consulting with these organizations to improve their product lines, expand their distribution channels through internal partnership agreements, and heighten brand value.

Aequus Pharmaceuticals Inc. (TSX:AQS.V) is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus' development stage pipeline includes several products in neurology and psychiatry with a goal of addressing the need for improved medication adherence through enhanced delivery systems. Aequus intends to commercialize its internal programs in Canada alongside its current portfolio of marketed established medicines and will look to form strategic partnerships that would maximize the reach of its product candidates worldwide. Aequus plans to build on its Canadian commercial platform through the launch of additional products that are either created internally or brought in through an acquisition or license; remaining focused on highly specialized therapeutic areas. Cannabis: July 2017 - Aequus Pharmaceuticals Inc., ("Aequus") (TSX VENTURE: AQS) (OTCQB: AQSZF), a specialty life sciences company focused on providing patients with differentiated and enhanced delivery systems for existing and approved drugs, and Scientus Pharma Inc., ("Scientus"), a biopharmaceutical company focused on R&D and product commercialization for extracts and formulations related to medical cannabinoids and their derivatives, announced today that they have signed a non-binding term sheet on a collaboration to develop, assess clinical performance, and commercialize a cannabinoid containing transdermal formulation designed and optimized to address both acute and chronic treatment of Resistant Epilepsy, and certain other neurological disorders. Scientus will be the supplier of specific cannabinoid extracts and will have an option to co-fund the clinical development of this program. The parties expect to expand the collaboration to additional product development programs in the future.

See the full stock directory here

Investor Resources